Compared to other breast cancer subtypes, TNBC tumors have higher immunogenicity, higher enrichment by tumor-infiltrating lymphocytes (TILs), and higher levels of programmed cell death ligand 1 (PD-L1) expression [1]. The gene discussed is CD274; the disease is neoplasm.